Home / News / India News / Article /
Biological E seeks EUA for Covid vaccine Corbevax for children in 5-12 age group: Official sources
Updated On: 09 March, 2022 12:04 PM IST | New Delhi | ANI
Recently, the Subject Expert Committee recommended Emergency Use Authorization (EUA) for Biological E's Covid-19 vaccine Corbevax for the age group of 12 to 18 years under certain conditions
Listen to this article :

Representative image
Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its Covid-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday.
The data has been submitted by the company to the Subject Expert Committee for beneficiaries between 5-12 years of age, the sources told ANI.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

